Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study - PubMed (original) (raw)

• Classification of current anticancer immunotherapies.
  Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
• Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.
  Jan M, Sperling AS, Ebert BL. Jan M, et al. Nat Rev Clin Oncol. 2021 Jul;18(7):401-417. doi: 10.1038/s41571-021-00479-z. Epub 2021 Mar 2. Nat Rev Clin Oncol. 2021. PMID: 33654306 Free PMC article. Review.
• Approaches to Managing Safety With Lenalidomide in Hematologic Malignancies.
  Blumel S, Broadway-Duren J. Blumel S, et al. J Adv Pract Oncol. 2014 Jul-Aug;5(4):269-79. doi: 10.6004/jadpro.2014.5.4.4. J Adv Pract Oncol. 2014. PMID: 26110071 Free PMC article. Review.
• [The consensus of the diagnosis and treatment of mantle cell lymphoma in China (2016 version)].
  Hematology Oncology Committee of China Anti-Cancer Association; Leukemia & Lymphoma Group Society of Hematology at Chinese Medical Association; Union for China Lymphoma Investigators. Hematology Oncology Committee of China Anti-Cancer Association, et al. Zhonghua Xue Ye Xue Za Zhi. 2016 Sep 14;37(9):735-741. doi: 10.3760/cma.j.issn.0253-2727.2016.09.002. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27719713 Free PMC article. Chinese. No abstract available.
• Current overview and treatment of mantle cell lymphoma.
  Schieber M, Gordon LI, Karmali R. Schieber M, et al. F1000Res. 2018 Jul 25;7:F1000 Faculty Rev-1136. doi: 10.12688/f1000research.14122.1. eCollection 2018. F1000Res. 2018. PMID: 30109020 Free PMC article. Review.